Table 5 Secondary efficacy variables at baseline, 30 and 90 days of study population
From: Botulinum toxin: could it be an effective treatment for chronic tension-type headache?
BTX | Placebo | P value | ||||
|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | |||
Duration of headache per day (h) | ||||||
Baseline | 8.50 | 1.09 | 8.86 | 1.03 | 0.381 | |
30 days | 6.93 | 0.83 | 8.07 | 0.92 | 0.002 | |
90 days | 6.29 | 0.91 | 7.57 | 1.34 | 0.006 | |
Number of days with acute headache medications/months | ||||||
Baseline | 11.14 | 2.59 | 10.71 | 2.33 | 0.650 | |
30 days | 7.43 | 1.09 | 9.64 | 2.02 | 0.001 | |
90 days | 6.43 | 1.16 | 8.36 | 1.65 | 0.001 | |